Tsai Capital Corporation, a New York-based growth equity investment firm with a 26-year track record of long-term, fundamental, research-driven investing, today announced the appointment of Richard A.
Rapala VMC Corporation, Inside Information, November 14, 2025 at 10:25 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION ...
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback